<DOC>
	<DOCNO>NCT00639210</DOCNO>
	<brief_summary>A Finnish Breast Cancer Group Study ( BREX 01-2004 ) . A multicenter phase III open randomise trial efficacy exercise prevention long-term adverse effect adjuvant treatment breast cancer recurrence woman primary breast cancer . The aim study investigate whether regular exercise training could reduce long-term side effect adjuvant treatment primary breast cancer improve quality life well .</brief_summary>
	<brief_title>BREAST CANCER AND EXERCISE</brief_title>
	<detailed_description>A multicenter phase III open randomise trial efficacy exercise prevention long-term adverse effect adjuvant treatment breast cancer recurrence woman primary breast cancer . The aim study investigate whether regular exercise training could reduce long-term side effect adjuvant treatment primary breast cancer improve quality life well . Large controlled prospective study need confirm preliminary finding exercise benefit cancer patient , investigate type , frequency , intensity tolerability exercise training cancer patient , clinical recommendation give . Prevention osteoporosis , improvement weight control , muscular cardiovascular fitness wait . The second aim study investigate , whether regular exercise training reduces risk breast cancer recurrence , prevent disease reduce all-cause mortality cost effective woman primary breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporotic Fractures</mesh_term>
	<criteria>Histologically proven invasive breast cancer T14N03M0 , pre postmenopausal breast cancer patient treat adjuvant chemotherapy radiotherapy within 4 month patient start adjuvant endocrine therapy ( antiestrogens , aromatase inhibitor , LHRH agonists , combination ) later 4 month earlier , age 35 68 year , sign informed consent prior begin protocol specific procedure Prior malignancy except basal cell carcinoma situ cervix carcinoma Male gender Haematogenous metastasis ( M1 ) No systemic adjuvant therapy Postmenopausal woman treat antiestrogens , tamoxifen toremifene , adjuvant treatment ( +/ radiotherapy ) Pregnancy recent lactation ( &lt; 1 year ) Severe cardiac disease ( New York Heart Association class III great ) , myocardial infarction within 12 month , uncontrolled hypertension Verified osteoporosis ( proximal femur lumbar spine tscore &lt; 2.5 fracture without trauma ) Concomitant medication affect calcium bone metabolism bisphosphonates , calcitonin , PTH , SERMs , oral corticosteroid ( 6 month ) , anticonvulsant ( fenytoin , carbamazepine ) prolong heparin therapy Other disease affect calcium bone metabolism hyperthyroidism , newly diagnose hypothyroidism , primary hyperparathyroidism , renal failure , chronic hepatic disease , organ transplant , Cushing 's syndrome , rheumatoid arthritis , chronic bowel diseases celiac disease , Chron disease history total ventricular resection Other serious illness medical condition , could contraindication exercise Patients capable training ( severe knee arthrosis , severe ligamental cartilage injury low extremity ) Residence one hour exercise centre Competitive athlete</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>exercise</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>fracture</keyword>
	<keyword>quality life</keyword>
</DOC>